The conversation around menopause has changed.
In November 2025, the U.S. Food and Drug Administration removed the boxed warning on systemic estrogen products that had been in place for more than two decades. The agency's review concluded that the warning had overstated the risks of hormone therapy for menopause symptoms and had kept many patients from being offered treatment that current evidence supports.
That's a meaningful shift. For years, primary-care offices either avoided menopause entirely or sent patients to a specialist they often couldn't get in to see. We're not doing it that way. Menopause is a normal stage of life, and the care for it belongs in the same office where you handle blood pressure, thyroid, and your annual physical.
At LAC Medical, we follow current FDA labeling. We use FDA-approved hormone therapy products — patches, oral progestogen, topical estrogen — and we manage them the same way we manage any other long-term medication: with a real conversation about risks and benefits, regular follow-up, and clear stopping rules if something isn't working.